MARIN

The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid? With the House’s proposed budget on the table, 20 million Americans on expanded Medicaid could be at risk. Plus, 12 states have "trigger laws" ready to roll back coverage. What’s at stake—and what’s next? Behind the Bill breaks it down. #BehindTheBill #Medicaid #HealthcarePolicy #BudgetDebate #HealthCoverage First Report Managed Care #FRMC

Your Strategic Compass for Market Access For over a decade, we've helped you navigate the complexities of oncology market access. Now, we’re evolving. Introducing MARIN (Market Access Research Intelligence). The same expert team. A stronger vision. More clarity, more strategy, more impact. https://hubs.ly/Q03bnK7X0 #MARIN #OncologyMarketAccess #Biopharma #Intelligence #StrategicGuidance #HMPMarketAccessInsights #HMPGlobal #MarketAccess #MarketAccessResearchIntelligence

Did you miss our latest blog post? Check it out to see what manufacturers should do to streamline PA approvals and support providers where they need it most? #HMPMarketAccessInsights #PriorAuthorization #OncologyMarketAccess #MarketAccess

In a surprising move, U.S. Department of Health and Human Services (HHS) eliminated public participation in rulemaking for many health programs. While Medicare/Medicaid may keep comment periods, other policies could now change without public input. Why does this matter? Read this week’s #BehindtheBill to find out. #HMPMarketAccessInsights #BehindTheBill #HealthcarePolicy #HHS #RegulatoryChanges #FRMC First Report Managed Care

Some of us run on coffee, but Cindy Chen runs on sugar! ?? An avid pastry connoisseur, she knows her way around the best bakeries and patisseries in Bay Area. But Cindy doesn’t just keep us well-fed—she keeps our data on point. As the lead on data integrity and the Oncology Clinical Pathway Report, she ensures our research is accurate, reliable, and actionable. This year, she’s diving into product development, helping make our insights even more accessible for clients. Have a bakery recommendation for Cindy? Drop it in the comments! ?? https://hubs.ly/Q038Chg00 #HMPMarketAccessInsights #MeetTheTeam #InsightsExperts #DataDrivenDecisions #Teamwork

?? Heading to #AMCCBS25 next week in DC? Emma Bijesse, Ramon Auciello, and Lee Blansett will be on-site and ready to connect! If you're interested in our 2025 report offerings or want to see our latest data visualization tools for the IDN Report and Pathways Report, let’s chat. ?? Schedule time with us here: https://hubs.ly/Q038Ny_C0 #HMPMarketAccessInsights #OncologyMarketAccess #CommunityOncology #ClinicalPathways #ACCC #MarketAccess #Oncology #DataInsights

Got a question about payer oncology? Chris Van Denburg has your answer! While most of us are winding down, Chris is happily getting lost in reams of data sources late into the night. What Chris loves most about is role? Interacting with our clients, helping them see challenges through fresh perspectives, and uncovering those golden nuggets of information that shape strategic plans and everyday actions. ?? ?? Share some of your interests with Chris in the comments! What’s one insight or “nugget” you’ve found recently that changed your approach? https://hubs.ly/Q036NKSJ0 #HMPMarketAccessInsights #MeetTheTeam #InsightsExperts #OncologyStrategy #Teamwork

The Promise & Complexity of Bispecific Antibodies Chris Van Denburg explores why bispecific antibodies hold great potential for cancer treatment—and why adoption has been slower than expected. From managing immune-related toxicities to navigating reimbursement hurdles, learn about the factors influencing their uptake in the community setting. Dive Deeper: https://lnkd.in/gTyK77Cv Are you a community oncologist looking to stay informed on the latest in cancer treatment? Consider attending Great Debates in Solid Tumors. ???gdsolidtumors.com #BispecificAntibodies #Oncology #Cancer #MedicalEducation

Just two weeks into RFK Jr.'s tenure as HHS Secretary, major shifts are underway—from FDA staffing changes to a renewed focus on preventative care and alternative medicine. ?Get the full breakdown in this week’s #BehindtheBill ?? #HMPMarketAccessInsights #FirstReportManagedCare #HealthcarePolicy #PreventativeCare #FDA #Pharma First Report Managed Care

Our latest analysis breaks down how Maximum Fair Prices (MFPs) could reshape provider margins and what that means for your engagement strategy. Get the insights you need for 2026 planning. Download the whitepaper now: https://lnkd.in/eamnC4dA #HMPMarketAccessInsights #MarketAccess #MedicareNegotiation #Pharma